Incision raises €5M for surgical training platform
Fraser has acted as exclusive financial advisor to Incision Group B.V., a leading platform for surgical performance and online training, on its €5M Series A financing led by SHS and Rubio Impact Ventures. The new investment enables the global healthtech company to expand its international commercial operations and further develop new cutting-edge modules.
Amsterdam – May 27, 2021. Incision, a platform for surgical performance and online training, has received €5M funding in its Series A funding round from SHS and Rubio Impact Ventures. The two new investors will support Incision’s mission to become the leading platform for surgical care and create an ecosystem where high-quality surgical knowledge is accessible to everyone, facilitating the dissemination and standardisation of best practices. The new investment will accelerate Incision’s international expansion and new product launches.
SHS is an investment company that focuses on medical technology, life science, diagnostics and digital health. "At SHS we have been actively following the trends in the OR and evaluating a range of investment opportunities. We believe that Incision’s experienced team, its product offering and strategy are the right ingredients to build a European Healthcare champion”, says David Wehner, Senior Investment Manager at German medtech investor SHS. And SHS partner Dr. André Zimmermann adds: “Incision fits perfectly with our investment strategy of supporting European growth companies in the healthcare sector with our SHS industry expertise and long-standing network."
Rubio Impact Ventures is a team of entrepreneurs, investors and change- makers who are advocates of innovation and help valuable companies and entrepreneurs to solve the biggest problems of today’s society. Eske Scavenius, the Investment Director at Rubio Impact Ventures comments: “We are excited to back the stellar Dutch team at Incision on their mission to optimize performance in the OR and reduce surgical complications. Their impact is already global in nature, and is set to scale up to 10,000 clinics worldwide“
Incision was founded in 2014 by Prof. Dr. Theo Wiggers and healthcare entrepreneurs. Incision’s goal is to connect 10,000 clinics and improve 100 million operations per year. To achieve this, Incision is building a platform for surgical knowledge, supporting surgical performance and training so all clinics can achieve results at par with the top clinics in the world. Incision is currently active in 18 countries worldwide, serving over 200 hospital clients.
With its next wave of expansion to the UK, Scandinavia, Belgium and the Middle East, Incision will be growing its international footprint further. Also, a number of features will be launched, enriching the platform with new learning materials, effective workflows, and sharing of best practices to improve on-the- job performance of individuals and teams.
Ritsaart van Montfrans, CEO of Incision: "We are working closely with our hospital clients worldwide to grow the Incision platform. We are launching new products with them to boost the performance of their surgical teams and adding new users every day. We are very excited to have SHS & Rubio on-board as VCs so we can accelerate our international rollout and move faster towards our goal to connect 10,000 clinics with our platform”
We are a dedicated M&A advisory and investment firm, partnering with leaders in Europe’s technology sectors to unlock next levels of growth and success. Based in Berlin, London and Chicago, we advise entrepreneurs, senior management and boards on their most important strategic decisions and transactions. Alongside our clients and partners, we also invest into selected opportunities. For further information, please visit www.fraserfinance.com.